US Stocks
/
Acumen Pharmaceuticals, Inc. Share Price
Acumen Pharmaceuticals, Inc. Share Price

Acumen Pharmaceuticals, Inc. Share Price

NASDAQ: ABOS | Micro Cap
$2.10
+$0.01 (0.48%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Acumen Pharmaceuticals, Inc. Stock Performance

Open
$2.03
Prev. Close
$2.09
Circuit Range
N/A
Day Range
$2.03 - $2.13
Year Range
$1.52 - $3.60
Volume
21,168
Average Traded
$2.08

Acumen Pharmaceuticals, Inc. Share Price Today

As of 9 October 2026, Acumen Pharmaceuticals, Inc.'s share price is $2.10. The stock opened at $2.03, compared to its previous close of $2.09. During today's trading session, Acumen Pharmaceuticals, Inc.'s share price traded between $2.03 and $2.13, with an average price of $2.08. Over the past 52 weeks, the stock has recorded a high of $3.60 and a low of $1.52. In terms of performance, Acumen Pharmaceuticals, Inc.'s share price has declined by 12.13% over the last six months and is down 3.45% on a year-on-year basis.

Acumen Pharmaceuticals, Inc. Share Price Chart

$2.03$2.13
L
Show Current Price
H

Acumen Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$127.18M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.45
Revenue (TTM)
$0.00
Return On Equity (TTM)
-183.44%
Profit Margin
N/A
Debt to Equity
0.55
Quarterly Earnings Growth YoY
-23.71%

Acumen Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$26.45-$25.14-$20.74-$32.72
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A4.95%17.50%-57.76%

Acumen Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$42.86-$52.37-$102.33-$121.34
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-22.19%-95.40%-18.58%

About Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Acumen Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.17
$2.10
-5.62%
Sep 2026
$2.86
$2.23
-26.81%
Aug 2026
$2.13
$3.04
+41.40%
Jul 2026
$2.59
$2.15
-19.17%
Jun 2026
$2.60
$2.66
+1.92%
May 2026
$2.38
$2.61
+9.21%
Apr 2026
$2.46
$2.39
+1.49%
Mar 2026
$3.07
$2.35
-25.59%
Feb 2026
$2.54
$3.17
+21.97%
Jan 2026
$2.09
$2.60
+24.46%
Dec 2025
$1.86
$2.08
+10.61%
Nov 2025
$2.17
$1.89
-13.33%

ABOS Share Price FAQs

What is Acumen Pharmaceuticals, Inc. share price today?

chevron-up
Acumen Pharmaceuticals, Inc. share price today is $2.10 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Acumen Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Acumen Pharmaceuticals, Inc. stock is $3.60, while the 52 week low is $1.52 as of 9 Oct '26.

What is ABOS's market capitalisation today?

chevron-up
ABOS market capitalisation is $127.18M as of October 9, 2026, at 4:47 pm IST.

What is ABOS's net income for the last quarter?

chevron-up
ABOS's net income for the last quarter is -32.72B USD.

What is the 5 year returns of ABOS?

chevron-up
The 5 year returns of ABOS is -84.87% as on 9 Oct '26.

What is the high & low stock price of ABOS today?

chevron-up
ABOS stock price hit a high of $2.13 and low of $2.03 as of 9 Oct '26.

Can I buy ABOS shares in India?

chevron-up
Yes. You can buy ABOS in India by opening an international trading account.